Please login to the form below

Not currently logged in
Email:
Password:

Sudler & Hennessey cofounder dies

Matt Hennessey, one of Sudler & Hennessey's (S&H) cofounders has died of cancer at the age of 95

Matt Hennessey, one of Sudler & Hennessey's (S&H) cofounders has died of cancer at the age of 95.

Matthew Joseph Hennessey was born in 1916, in Brooklyn, New York. Hennessey began his art career in 1936, working with Arthur Sudler in his graphic design studio where Sudler set up shop with E R Squibb and Sons as his charter client. Five years later, they founded Sudler & Hennessey, with Hennessey as president and Sudler as chairman.

Art directors hired by Hennessey included George Lois, Helmut Krone, Ernie Smith, Herb Lubalin, Charles Addams, Ronald Searle, and Andy Warhol.

Hennessey was a believer in the power of visual communication, and it was at the helm when the original NBC peacock was created by S&H.

After serving in the army during World War II, Hennessey returned to the agency and, in 1953, made the decision to focus on the pharmaceutical industry. By 1968, S&H was the largest medical agency and held that distinction for more than 20 years.

After Art Sudler passed away, Sudler & Hennessey became part of Young & Rubicam, now with a network that spans the globe. Hennessey was inducted into the Medical Advertising Hall of Fame in 1998.

Jed Beitler, chairman and CEO worldwide, S&H, said: "Matt retired in 1984, but his legacy to the business world lives on. His vision helped to lay the foundation for the success S&H enjoys today on a global scale."

26th April 2011

Share

Subscribe to our email news alerts

Featured jobs

PMHub

Add my company
Merrill Brink International

Merrill Brink International is a leading provider of life sciences, legal, financial, manufacturing and corporate language solutions for global companies....

Latest intelligence

Report: Reinventing product and portfolio value for the biopharmaceutical industry
Gain practical advice on determining and communicating product and portfolio value, including why, in fast-paced and evolving markets, you need to consider the evidence requirements of a growing network of...
Neil Thompson
How AI is finally helping rare diseases gain more than just attention
By Neil Thompson...
Is communication failing us?
Compelling people to care in a world oversaturated with news and information...